For citations:
Borisevich S.V., Rubtsov V.V., Pistsov M.N., Loginova S.Ya., Krotkov V.T., Sakharov R.V., Kuznetsov D.A., Sizikova T.E., Savenko S.V., Yanovskaya K.I., Ovchinnikov A.V., Mironov A.N. Protective efficacy of combined monoclonal antibody docaravimab and miromavimab preparation against classical rabies virus: A preclinical study in BALB/c mice. Biological Products. Prevention, Diagnosis, Treatment. 2025;25(4):376-388. (In Russ.) https://doi.org/10.30895/2221-996X-2025-25-4-376-388
Email this article 